The Anti-Diabetes Drugs market in Eastern Asia has been experiencing significant growth in recent years.
Customer preferences: There is a growing demand for anti-diabetes drugs in Eastern Asia due to the rising prevalence of diabetes in the region. This has led to an increase in the number of patients seeking treatment for the disease. Additionally, there is a growing awareness among patients about the importance of managing their diabetes through medication.
Trends in the market: China is the largest market for anti-diabetes drugs in Eastern Asia, accounting for a significant share of the overall market. The country's aging population and changing lifestyle habits have contributed to the rise in diabetes cases, creating a significant demand for anti-diabetes drugs. Japan is another important market in the region, with a large number of patients seeking treatment for type 2 diabetes.
Local special circumstances: One of the unique challenges facing the anti-diabetes drugs market in Eastern Asia is the lack of access to healthcare in some rural areas. This has made it difficult for patients in these areas to receive proper treatment for their diabetes. Additionally, there is a cultural stigma associated with diabetes in some parts of the region, which has led to a reluctance among some patients to seek treatment.
Underlying macroeconomic factors: The rapid economic growth in Eastern Asia has led to changes in lifestyle habits, including a shift towards a more sedentary lifestyle and a diet high in sugar and fat. This has contributed to the rise in diabetes cases in the region. Additionally, the aging population in countries like China and Japan has led to an increase in chronic diseases like diabetes. The growing middle class in the region has also led to an increase in demand for healthcare services, including anti-diabetes drugs.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
